201 related articles for article (PubMed ID: 24704333)
1. Recombinant influenza H1, H5 and H9 hemagglutinins containing replaced H3 hemagglutinin transmembrane domain showed enhanced heterosubtypic protection in mice.
Liu Q; Liu K; Xue C; Zhou J; Li X; Luo D; Zheng J; Xu S; Liu GD; Cao Y
Vaccine; 2014 May; 32(25):3041-9. PubMed ID: 24704333
[TBL] [Abstract][Full Text] [Related]
2. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
Liu Q; Xue C; Zheng J; Liu K; Wang Y; Wei Y; Liu GD; Cao Y
Vaccine; 2015 Jul; 33(32):4035-40. PubMed ID: 26100927
[TBL] [Abstract][Full Text] [Related]
3. Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
Wang Y; Zhang Y; Wu J; Lin Y; Wu Z; Wei Y; Wei X; Qin J; Xue C; Liu GD; Cao Y
Virus Res; 2017 Oct; 242():16-23. PubMed ID: 28912070
[TBL] [Abstract][Full Text] [Related]
4. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
[TBL] [Abstract][Full Text] [Related]
5. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
6. Recombinant influenza H9N2 virus with a substitution of H3 hemagglutinin transmembrane domain showed enhanced immunogenicity in mice and chicken.
Zhang Y; Wei Y; Liu K; Huang M; Li R; Wang Y; Liu Q; Zheng J; Xue C; Cao Y
Sci Rep; 2017 Dec; 7(1):17923. PubMed ID: 29263359
[TBL] [Abstract][Full Text] [Related]
7. Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes.
Tan L; Lu H; Zhang D; Tian M; Hu B; Wang Z; Jin N
Virol J; 2010 Dec; 7():363. PubMed ID: 21134292
[TBL] [Abstract][Full Text] [Related]
8. Vaccine Efficacy of Inactivated, Chimeric Hemagglutinin H9/H5N2 Avian Influenza Virus and Its Suitability for the Marker Vaccine Strategy.
Kim SM; Kim YI; Park SJ; Kim EH; Kwon HI; Si YJ; Lee IW; Song MS; Choi YK
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077631
[TBL] [Abstract][Full Text] [Related]
9. Cross-protective immunity against influenza A/H1N1 virus challenge in mice immunized with recombinant vaccine expressing HA gene of influenza A/H5N1 virus.
Yang S; Niu S; Guo Z; Yuan Y; Xue K; Liu S; Jin H
Virol J; 2013 Sep; 10():291. PubMed ID: 24053449
[TBL] [Abstract][Full Text] [Related]
10. Intranasal vaccination with H5, H7 and H9 hemagglutinins co-localized in a virus-like particle protects ferrets from multiple avian influenza viruses.
Tretyakova I; Pearce MB; Florese R; Tumpey TM; Pushko P
Virology; 2013 Jul; 442(1):67-73. PubMed ID: 23618102
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.
Nagy A; Lee J; Mena I; Henningson J; Li Y; Ma J; Duff M; Li Y; Lang Y; Yang J; Abdallah F; Richt J; Ali A; García-Sastre A; Ma W
Vaccine; 2016 May; 34(23):2537-45. PubMed ID: 27102817
[TBL] [Abstract][Full Text] [Related]
12. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
Allen JD; Ross TM
J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635
[TBL] [Abstract][Full Text] [Related]
13. Protective Efficacy of Recombinant Influenza Hemagglutinin Ectodomain Fusions.
Mittal N; Sengupta N; Malladi SK; Reddy P; Bhat M; Rajmani RS; Sedeyn K; Saelens X; Dutta S; Varadarajan R
Viruses; 2021 Aug; 13(9):. PubMed ID: 34578291
[TBL] [Abstract][Full Text] [Related]
14. Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
Yoshida R; Igarashi M; Ozaki H; Kishida N; Tomabechi D; Kida H; Ito K; Takada A
PLoS Pathog; 2009 Mar; 5(3):e1000350. PubMed ID: 19300497
[TBL] [Abstract][Full Text] [Related]
15. H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model.
Carreño JM; Strohmeier S; Kirkpatrick Roubidoux E; Hai R; Palese P; Krammer F
mBio; 2020 Dec; 11(6):. PubMed ID: 33323511
[TBL] [Abstract][Full Text] [Related]
16. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
[TBL] [Abstract][Full Text] [Related]
17. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
18. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
[TBL] [Abstract][Full Text] [Related]
19. A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.
De Marco D; Clementi N; Mancini N; Solforosi L; Moreno GJ; Sun X; Tumpey TM; Gubareva LV; Mishin V; Clementi M; Burioni R
PLoS One; 2012; 7(4):e34415. PubMed ID: 22496802
[TBL] [Abstract][Full Text] [Related]
20. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y
Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]